Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

E Rossouw, Jacques; L Anderson, Garnet; L Prentice, Ross; Z LaCroix, Andrea; Kooperberg, Charles; L Stefanick, Marcia; D Jackson, Rebecca; A A Beresford, Shirley; V Howard, Barbara; C Johnson, Karen; Morley Kotchen, Jane; Ockene, Judith; Group for the Women's Health Initiative Investigators, Writing

doi:10.1001/jama.288.3.321

Public

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Published in JAMA • Jul 17, 2002

NobleIDark:/48914/w1/20260526/DF59FAC1Record on NobleID

Authors:

Jacques E Rossouw

,

Garnet L Anderson

,

Ross L Prentice

Abstract

CONTEXT: Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy postmenopausal women remains uncertain. OBJECTIVE: To assess the major health benefits and risks of the most commonly used combined hormone preparation in the United States. D...

Discussions